The Swiss Competition Commission has charged the manufacturers of male impotence drugs with price fixing. The commission said Pfizer, Eli Lilly and Bayer made "inadmissible vertical competition agreements" that maintained...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Swiss Charge Pfizer, Eli Lilly, Bayer With Price-Fixing Male Impotence Drug | AHN
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account